Precision BioLogic Inc., a developer of hemostasis diagnostic products, has completed the acquisition of Affinity Biologicals Inc., a manufacturer of reagents and kits used in hemostasis and thrombosis research and diagnostics. “This acquisition marks an important step in the development of our company and execution of our strategic plan,” says Paul Empey, president & CEO of Precision BioLogic.…